Patient on insulin glargine 24 U in the morning and sulfonylurea‑metformin (Glavumet) scheduled at 6 pm has a capillary glucose of 13.5 mmol/L at 5:30 pm; what is the appropriate management?

Immediate Management of Pre-Dinner Hyperglycemia (13.5 mmol/L at 5:30 PM)

Administer 2 units of rapid-acting insulin (lispro or aspart) immediately as a correction dose, then give the scheduled Glavumet at 6 PM, and reassess the insulin regimen within 24–48 hours because a glucose of 13.5 mmol/L (243 mg/dL) at 5:30 PM indicates both inadequate basal coverage and the need for scheduled prandial insulin. 1, 2

Immediate Correction Dose

• For pre-meal glucose >250 mg/dL (13.9 mmol/L), administer 2 units of rapid-acting insulin (lispro, aspart, or glulisine) as a correction dose. 2
• A glucose of 13.5 mmol/L (243 mg/dL) falls just below this threshold but warrants correction given the proximity to the meal and the pattern of persistent hyperglycemia. 2
• Administer the correction dose 0–15 minutes before the 6 PM meal to achieve optimal post-prandial control. 2
• Give the scheduled Glavumet (sulfonylurea-metformin combination) at 6 PM as prescribed. 1

Why This Glucose Level Signals Regimen Failure

• A pre-dinner glucose of 13.5 mmol/L indicates that the current regimen—24 units of Lantus in the morning plus Glavumet at 6 PM—is fundamentally inadequate and requires immediate restructuring. 1, 2
• This level of hyperglycemia reflects both insufficient basal insulin coverage throughout the day and the complete absence of scheduled prandial insulin to address meal-related glucose excursions. 1, 2
• Relying solely on correction doses without scheduled prandial insulin is explicitly condemned by major diabetes guidelines as reactive rather than preventive therapy. 2

Urgent Regimen Restructuring (Within 24–48 Hours)

Basal Insulin Adjustment

• Increase Lantus from 24 units to 28–32 units (increment of 4 units) and administer at bedtime rather than morning to provide better overnight and daytime basal coverage. 1, 2
• The current morning dosing of Lantus may contribute to inadequate afternoon/evening basal support, as evidenced by the 5:30 PM hyperglycemia. 1, 2
• Titrate basal insulin by 4 units every 3 days if fasting glucose remains ≥180 mg/dL (10 mmol/L), targeting a fasting range of 80–130 mg/dL (4.4–7.2 mmol/L). 1, 2

Initiate Scheduled Prandial Insulin

• Begin 4 units of rapid-acting insulin before dinner (or 10% of the current basal dose) as a scheduled prandial dose, not just as correction. 1, 2
• Administer prandial insulin 0–15 minutes before the evening meal to cover the carbohydrate load. 2
• Titrate the dinner prandial dose by 1–2 units every 3 days based on 2-hour post-prandial glucose readings, targeting <180 mg/dL (<10 mmol/L). 1, 2

Sulfonylurea Management

• Reduce or discontinue the sulfonylurea component of Glavumet when initiating basal-bolus insulin to prevent additive hypoglycemia risk. 2, 3
• Continue the metformin component at maximum tolerated dose (up to 2000–2550 mg daily), as metformin reduces total insulin requirements by 20–30% and provides superior glycemic control when combined with insulin. 2, 4

Monitoring Requirements

• Check fasting glucose daily to guide basal insulin adjustments. 1, 2
• Measure pre-dinner glucose before each evening meal to calculate correction doses. 2
• Obtain 2-hour post-prandial glucose after dinner to assess prandial insulin adequacy. 1, 2
• Reassess the insulin regimen every 3 days during active titration. 1, 2

Critical Threshold Warning

• When basal insulin approaches 0.5 units/kg/day (approximately 35–40 units for most adults) without achieving glycemic targets, stop further basal escalation and focus on intensifying prandial insulin to avoid "over-basalization." 1, 2
• Clinical signs of over-basalization include basal dose >0.5 units/kg/day, bedtime-to-morning glucose differential ≥50 mg/dL, hypoglycemia episodes, and high glucose variability. 2

Hypoglycemia Management

• Treat any glucose <70 mg/dL (<3.9 mmol/L) immediately with 15 g of fast-acting carbohydrate, recheck in 15 minutes, and repeat if needed. 1, 2
• If hypoglycemia occurs without an obvious cause, reduce the implicated insulin dose by 10–20% before the next administration. 1, 2

Common Pitfalls to Avoid

• Do not rely solely on correction insulin without scheduled basal and prandial doses; this reactive approach is condemned by major diabetes guidelines and leads to dangerous glucose fluctuations. 2
• Do not delay adding prandial insulin when pre-meal glucose consistently exceeds 180 mg/dL (10 mmol/L); prolonged hyperglycemia increases complication risk. 1, 2
• Never use rapid-acting insulin at bedtime as a sole correction dose, as this markedly raises nocturnal hypoglycemia risk. 2
• Do not discontinue metformin when intensifying insulin therapy unless contraindicated, as this leads to higher insulin requirements and worse outcomes. 2, 4

Expected Clinical Outcomes

• With properly implemented basal-bolus therapy, approximately 68% of patients achieve mean glucose <140 mg/dL (7.8 mmol/L), compared with 38% using inadequate correction-only approaches. 2
• An HbA1c reduction of 2–3% is achievable within 3–6 months with intensive insulin titration combined with metformin. 2
• Properly executed basal-bolus regimens do not increase overall hypoglycemia incidence compared with inadequate sliding-scale approaches. 2